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ABSTRACT
USING AND DEVELOPING OPTICAL IMAGING MODALITIES TO INVESTIGATE
METABOLIC AND STRUCTURAL ALTERATIONS IN RODENT INJURY MODELS
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Optical fluorescence imaging is one of the vastly growing fields of imaging used in a broad
variety of preclinical investigation with great interest in translating its principles into clinical
applications. Optical fluorescence imaging provides images of functional and structural changes
with cellular and subcellular resolution in tissues at a low-cost. This technique takes advantage
of the absorption of light photons at a specific wavelength by intrinsic or extrinsic fluorophores
and emission of photons at characteristic wavelengths. The characteristics of the emitted
wavelengths such as their energy and illuminance give substantial information of the imaged
tissue. In the research presented here, we probe two Krebs cycle intrinsic fluorescence metabolic
coenzymes, reduced nicotinamide adenine dinucleotide (NADH) and oxidized flavin adenine
dinucleotide (FAD) to study metabolic status changes during a human disease.
The objective of my research can be categorized into two themes; I) Designing an optical
imaging instrument called an in vivo fluorescence imager to quantitatively investigate the
metabolic changes in tissue and customizing it to be suitable for human/clinical studies. II)
Using optical imaging techniques to quantitatively investigate the 3D anatomical structure
changes in vessel structure of organs.
ii

in vivo fluorescence imager can image many intrinsic and extrinsic fluorophores. However, we
used it to track mitochondria bioenergetics NADH and FAD in wounds of diabetic mice. We also
define the redox ratio (NADH/FAD) as a biomarker to investigate the effect of 670 nm photobiomodulation in those wounds. In another study, we have used 3D optical imaging system on
the biopsy of diabetic wounds to confirm the results from the in vivo fluorescence imager. It
showed that our in vivo fluorescence imager could successfully track the changes in the
metabolic state of non-treated and treated diabetic wounds with 670 nm photobiomodulation.
Additionally, I validated a 3D vessel segmentation method developed in our lab by employing
Murray’s law. Furthermore, I used the 3D optical cryo-imaging system and the segmentation
method to quantitatively study the 3D vessel structure changes in irradiated animal model. The
result of this study showed that radiation can adversely change the vasculature in irradiated
kidneys and negatively affect kidney perfusion.
In summary, my major contribution has been in device implementation and applications of
imaging and image processing in studies of animal model diseases of humans.
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Introduction
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1. Introduction
Biophotonics is the study of the light and photonics process in biological systems. One of the most
important aspects of this field is tracking the extrinsic and intrinsic fluorescence agents by imaging
and sensing cells and tissues.
The research presented here involves the use and development of different imaging instruments
and image processing techniques to investigate the effect of multiple diseases on the metabolic
state of different tissues by tracking intrinsic fluorescence imaging. The obtained information can
be of great interest in identifying and implementing interventions to treat or prevent diseases.

1.1.

Major contributions

During my research activities at Biophotonics lab, I have contributed to the following three major
areas:
1.1.1.

Bio-instrumentation

I have contributed to the new design/upgrade of two devices as one major contribution to my thesis.
These two devices are called optical in vivo fluorescence imager and fluorometer. Both instruments
are used to track the intrinsic mitochondrial fluorophores, NADH and FAD. The former uses
imaging techniques and the later uses signaling techniques. I utilized different optical components
to design and develop the optical in vivo fluorescence imager. Then, by using LabVIEW, I have
developed a user-interface that accelerated the different parts of experiments by automation of
different parts synchrony and image acquisition. The clinical use of optical in vivo fluorescence
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imager is in process. For fluorometer, I upgraded the systems by employing better light source and
improving the user-interface code.
1.1.2. Mathematical Validation
By using the 3D fluorescence cryo-imager and a segmentation method developed in Biophotonics
lab, the anatomical 3D-vessel structure of different organs could be extracted. However, a coregistration was needed to validate this method. By employing the minimum work hypothesis of
Murray’s law, I was able to mathematically validate this method. I also used this method to
computationally assess the effect of irradiation on the anatomical renal vessel structures and
endothelium changes.
1.1.3. Experimentation, image acquisition, and data interpretation
I was involved in two experiments during my studies, 1) the effect of far-red photobiomodlation
on diabetic wounds of mice 2) the effect of 12.5 Grey irradiation on renal vessel structure of rats.
For both experiments I participated on experimentation, image acquisition and data interpretation.
Conducting all these experimental studies required the assembly of the required tools and
designing experimental protocols to study the metabolism in the cryogenic, in vivo, and ex vivo
regiments. For each regime used in this study, unique treatment, and preparation of the tissues, as
well as proper imaging and acquisition methods are required. Moreover, different methods and
techniques of image processing was used for each of these studies. The samples and surgery needs
are provided by the Medical College of Wisconsin, the University of Wisconsin-Madison, and the
College of Nursing at the University of Wisconsin-Milwaukee. My M.Sc, contributions and
research are published in the following peer-reviewed journals and conference proceedings.
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Journal Publications
J1.

S Mostaghimi, S Mehrvar, F Foomani, N Narayanan, B Fish, AKS Camara, MM Medhora,
and M. Ranji, “Quantification of Radiation Induced Renal Vascular Structure (Vasculature)
Injuries: A time-response and dose-response study.,” (In submission process)

J2.

F. Foomani, JA. Jarzembowski, S. Mostaghimi, S. Mehrvar, SN. Kumar and M. Ranji,
“Optical Metabolic Imaging of Mitochondrial Dysfunction on HADH Mutant Newborn Rat
Hearts,” (submitted to JTHEM)

J3.

S Mehrvar, S Mostaghimi, F Foomani, N Narayanan, B Fish, AKS Camara, MM Medhora,
and M. Ranji, “3D vascular-metabolic imaging using inverted intrinsic fluorescence,” (Under
revision)

J4.

S Mostaghimi, S Mehrvar, FH Foomani, B Abroe, JT Eells, S Gopalakrishnan and M Ranji,
“670nm Photobiomodulation improves the Mitochondrial Redox State of Diabetic Wounds,”
(2021)

J5.

S Mehrvar, FH Foomani, S Shimada, C Yang, N Zheleznova, S Mostaghimi, A Cowley, and
M Ranji, “The Early Effects of Uninephrectomy on Rat Kidney Metabolic State Using
Optical Imaging,” (2020)

Selected Conference Proceedings and Presentations
C1. S Mostaghimi, S Mehrvar, FH Foomani, J Narayanan, JT Eells, AKS Camara, B Fish, M
Medhora, and M Ranji, “Vascular injury in lung vessels post-irradiation: a dose and time
response case study,” CLEO, San Diego (2021)
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C2. S Mostaghimi, S Mehrvar, FH Foomani, B Abroe, JT Eells, M Ranji, and S Gopalakrishnan,
“The Effect of NIR Light Treatment in Metabolic State of Diabetic Wounds,” BMES,
Philadelphia (2019)
C3. S Mehrvar, F Foomani, S Mostaghimi, M Medhora, AKS Camara, and M Ranji, “Radiationinduced Injuries to Rat Kidney Vasculature,” BMES, Philadelphia (2019)
C4.

FH Foomani, S Mehrvar, S Mostaghimi, S Shimada, C Yang, N Zheleznova,
AW Cowley Jr., and Mahsa Ranji, “The Early Effects of Uninephrectomy on Rat Kidney
Metabolic State Using Optical Imaging,” BMES, Philadelphia (2019)

1.1.

Biological background

1.1.1. Cell biology
Cells are the fundamental and smallest units of life[2]. All living organisms are made of cells.
Cells can be classified into two groups based on their structure: eukaryotes and prokaryotes. The
former refers to the cells with many or one nucleus and the latter refers to the cells without a
nucleus. Eucaryotic are more complex than prokaryotic cells and have more elaborate intracellular
compartments. Their metabolism depends on the oxidation of organic molecules by one of the
most important organelles in the cell, mitochondrion. A mitochondrion contains a smooth outer
membrane and a convoluted inner membrane [3]. The prominent role of mitochondria is to produce
the units of energy, ATP, and to regulate the metabolism of a cell [4]. Cell produces ATP with
breakdown of glucose and other substrates through glycolysis, Krebs cycle and oxidative
phosphorylation. However, the synthesis of ATP mostly happens through a set of chemical
reaction reactions via electron transport chain, located on the inner membrane of mitochondrion
[3]. At first, during glycolysis two NADH molecules are produced to serve as electron donors to
5

the electron transport chain. Glycolysis is a cytoplasmic pathway that breaks glucose into two
pyruvate molecules that enter the Krebs cycle. During pyruvate decarboxylation, FAD is reduced
to FADH2 which further will be used in the electron transport chain as well [5, 6]. The synthesis
of ATP requires a proton gradient that happens through the pumping of electrons from the
mitochondria matrix into mitochondrial intermembrane space. These electrons are obtained from
electron donation of NADH to complex I and FADH2 to complex II of the electron transport chain.
In the end, complex V of electron transport chain is turned by the force of proton gradient, which
facilitates the addition of a phosphate to adenosine diphosphate (ADP) to synthesis ATP [7, 8].
Figure 1

shows a schematic of the electron transport chain and the role of NADH and FADH2 in it.

Maintaining a proper pool of NADH and FAD is required for the proton gradient across the inner
and outer membrane of mitochondria. On one hand, Cells with high levels of NAD(P)H have
higher molecule for electron donation. As a result, they have a greater potential for producing ATP
through oxidative phosphorylation. On the other hand, cells with elevated levels of FAD and low
NAD(P)H have a higher demand for ATP production. Consequently, they need more oxidative
phosphorylation to meet this energy demand [6].
In summary, NADH and FAD play an important role in cellular metabolic activities. Luckily, due
to their fluorescent properties, they can be tracked to monitor cellular metabolism without
exogenous markers. Chance et al, for the first time, introduce the concept of optical redox ratio
and defined it as the ratio of NADH/FAD [9-13]. Redox ratio can be a global biomarker for the
metabolic activity of cells and is a direct biomarker of a change in tissue oxidation state. For
example, increases in oxidative metabolism rises the production of FAD and consumption of
NADH and as a result, a decrease in redox ratio. [14, 15]. Therefore, by developing modalities to
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track these biomarkers, we can detect irregularities in cellular metabolism and develop
interventions to prevent or reverse damages to cells.
.

Figure 1: Electron transport chain with electron donation of NADH and FADH2 to complex I and II. The proton
gradient at complex V facilitates the ATP synthesis [16]. Reprinted from Electron Transport chain, by Medbullets
Team, https://step1.medbullets.com/biochemistry/102051/electron-transport-chain, Copyright 2021 by Lineage
Medical.

1.1.2. Reactive oxygen species
Species that contain one or more unpaired electrons are called free radicals. Reactive oxygen
species (ROS) is a term used for both oxygen radicals and certain nonradical oxidizing agents that
can convert to free radicals [17]. Also, ROS are by-products of normal cell metabolism, produced
mainly by mitochondria, that play a vital role in cell signaling and redox regulating [18, 19]. A
massive amount of mitochondrial ROS production happens at the electron transport chain [19]. An
imbalance in antioxidant defense capacities and ROS production can lead to an oxidative stress
7

state [20]. Oxidative stress can damage proteins, nucleic acid and cell membrane, causing
cumulative damages contributing to numerous diseases [21]. Even a slight increase in oxidative
stress can lead to mitophagy, in which the mitochondria degrade but manage to recycle the released
nutrient. But, if the increase in the oxidative stress continues, the cell can go through apoptosis or
even necrosis, where the former is programmed cell death and the latter is abnormal cell death
[22]. Therefore, it is highly assumed that changes in the levels of ROS are associated with
mitochondria dysfunction that can lead to many diseases. The accumulation of NADH, an
autofluorescence ROS and an important co-enzyme in the electron transport chain, in the
dysfunctional mitochondria, is one of the examples [23]. As a result, the changes in the level of
ROS are greatly involved in the pathology of many diseases such as radiation injuries [24], type II
diabetes, cardiovascular diseases and muscular disorders [18]. In the studies presented here, beside
NADH we also track FAD which is a cofactor of one the most important source of ROS, xanthine
oxidoreductase (XOR) [17, 25]. As explained before, the ratio of NADH/FAD is a global
biomarker of cellular metabolism and can give us an understanding of the oxidative stress state of
the tissue.

1.2.

Tissue and Light interaction
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Tissue and light interaction effects can be observed in four ways. 1) reflection at a material surface
2) transmission when lights enter an environment (tissue) and passes through it. 3) absorption of
photon energy by the material (tissue). 4) multiple scattering of photons in the material (tissue).
Figure 2

is showing these different interactions [1].

Figure 2: four ways of light and tissue interactions: 1) reflection 2) transmision 3) absorption 4) scattering
[1]. Adapted from Light-tissue interactions, by G Kesier, 2016,Springer, Copyright by Springer
Science+Business Media Singapore 2016.

The absorption of light by a part of an organic molecule called chromophores can result in
fluorescence. Chromophores absorb light at a specific wavelength, and after a short time, emit it
with a longer wavelength [1]. This process is called fluorescence and is also related to the transition
of a molecule from the excited state to the ground state [26]. This process is illustrated in a
Jablonski diagram presented in Figure 3.

9

Figure 3: Jablonski Diagram. Fluorescnce happens when a molecules relaxes from an excited state to the
ground state [1]. Reprinted from Light-tissue interactions, by G Kesier, 2016,Springer, Copyright by Springer
Science+Business Media Singapore 2016.

In Figure 3, level S0 is the ground state energy, S1 and S2 are the first and second excited states. Each
of these states has different vibrational energy levels (shown by dashed oriental lines). The
transition between states is only possible through absorption or emission of quantized energy units,
photons. The absorption of photons is shown with upward sold vertical lines. In this process, a
photon (λ1 or λ2) can excite the molecule from S0 state to one of the higher vibrational levels of S1
or S2. Afterwards, the molecule will relax through a non-radiative internal process, shown with
dashed vertical lines, to the lowest vibrational level of S1. Subsequently, the molecule will relax
to the ground state (S0) through emitting a fluorescent photon (λ3 or λ4) resulting in fluorescence.
The solid downward vertical lines show the emission of fluorescent photons. Fluorescence
substances, fluorophore, are broadly classified into two groups of intrinsic or extrinsic
fluorophores. The biological molecules that can naturally go through the fluorescence process,
called autofluorescence or natural fluorescence, are called intrinsic fluorophores [1].

1.3.

Optical Metabolic Imaging
10

Optical imaging techniques, such as fluorescence and bioluminescence are emerging new
modalities, with widespread applications from molecular biology to disease diagnosis and therapy
[27, 28]. These techniques are becoming substantial because of reasons such as their ability to
provide: a) functional and structural changes with high resolution, b) information in microscopic
and macroscopic scale, c) quantitative information for follow-ups and objective diagnosis, and
being: d) being non-invasive, e) non-ionizing f) of low cost [28]. Optical metabolic images are
classified into three major groups:
1.3.1. Imaging oxygenation:
The oxygen that is received by respiratory system is transferred to the blood flowing through
pulmonary capillaries in the alveoli. The oxygenated blood then is moved to different organs by
cardiovascular system. Afterwards, the oxygen is released from hemoglobin and is diffuse to the
parenchymal cells in tissues. The transfused oxygen then is used in cytochrome oxide in the
electron transport chain of mitochondria to produce ATP [29]. Therefore, the whole body
respirometry is used to study the mitochondrial function. However, inferring the mitochondrial
dysfunction from changes in oxygen consumption is very difficult because of the shortcomings to
distinguishing whether a dysfunction in the mitochondria is because of a malfunction in the
consumption of ATP or in the supplying of substrates [30]. But optical absorption provides the
contrast for functional imaging since it provides information on the oxygen saturation of
hemoglobin. This will give us functional information of the intact microcirculation in vivo.
1.3.2. Autofluorescence imaging
NADH and FAD are two autofluorescence coenzymes involved in the synthetization of ATP.
Therefore, both coenzymes exist in oxidized (NAD+ and FAD) and reduced (NADH and FADH2)
forms. However, only NADH and FAD yield significant fluorescence. NADH is excite at 350 um
11

and emits maximum at 460 nm, while FAD is excited at 435 and has an emission maximum at
535. Since NADH has a higher quantum yield, it is associated with greater overall fluorescence
intensity. Although NADH and NAD(P)H are both autofluorescence with overlapping excitation
and emission spectra, studies have stablished that the autofluorescence is dominated by NADH.
Because, not only NADH has a higher quantum yield, but also, other studies show that metabolic
changes due to diseases such as cancer progression and drug treatments are ascribed to NADH [6].
Due to their role in cellular metabolism, NADH and FAD are used for molecular and cellular
imaging in small-animal models[27]. As a quantitative biomarker, the ratio of NADH/FAD is used
to describe the redox state of a tissue. Studies, conducted by many researchers, including our team,
has shown the changes of redox ratio are associated with metabolism injuries due to ischemiareperfusion [31-36], hyperoxia[37], diabetes[38], gene knockout[33, 39-42] and also with different
treatments responses such as photo-modulation therapy[43, 44], cancer therapy[45-47] and
mitigating radiation induced injuries[48].
1.3.3. Fluorescence imaging of Contrast Agents
The advantage of optical metabolic contrast agents (OMCA) imaging is the combination of high
spatial and temporal resolution with molecular-information. It can provide us with inter- and
intracellular activity in real time with subcellular resolution. Four of the main branches of OMCA
are nutrient uptake, enzyme activity, local chemical environment and cell signaling [6].
Most of the mitochondrial ROS productions are not fluorescence, therefore, by imaging the exogenous
fluorophores that are correlated with OS, the mitochondrial ROS production rate can be monitored.
May new modalities, methodologies and experimental protocols are advancing to quantify the
alteration in oxidative stress caused by various stress conditions in an uncoupled or inhibited state of
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cells. For example, the metabolic activity of cells under metabolic stressors such as hypoxia or high
glucose condition is being studied.

1.4.

Animal Injury Models

The animal injury models that have been studied are as follows:
Diabetic wound and photo-biomodulation (PBM): Chronic non-healing wounds are generally

believed to develop when the acute inflammatory phase of wound healing progresses to chronic
inflammation without resolution [49]. Chronic lower-extremity ulcers are a common complication
of diabetes, and approximately 15% to 25% of individuals diagnosed with diabetes will develop
lower extremity ulcers or foot ulcers at some point in their lifetime [50]. Moreover, diabetic ulcers
often persist for months to years in debilitated patients [51-53].These ulcers can become infected,
causing pain, discomfort, hospitalizations, and poor quality of life, which impose a tremendous
economic burden on the healthcare system with costs conservatively estimated for the management
of diabetic foot ulcers to be $9–13 billion in the United States [54]. This gives rise to a secondary
demand; a need to be able to monitor and track the cellular changes during the wound healing
trajectory, so that effective interventions can be identified and implemented during the early stages
benefiting the patient population [55].
Current treatment strategies for wound management in diabetic patients involve debridement,
topical antibiotics, the application of topical dressings, and oftentimes surgery [56].Clinical
Studies have shown that interventions like hyperbaric oxygen therapy (HBOT) and extracorporeal
shock wave therapy can improve the process of diabetic wound healing [57-61].
Photobiomodulation (PBM) using far-red (FR) to near-infrared (NIR) light is a non-invasive,
painless, and inexpensive therapeutic modality with documented efficacy in preclinical and
13

clinical studies in soft-tissue injuries and wound healing [62, 63]. In our studies, we investigated
the effect of 670 far-red photo-biomodulation on wound healing process of excisional wounds on
diabetic mice.
Partial body irradiation injury:

Radiation induces intravascular coagulation in kidneys [64], leading to many vascular diseases
such as renal artery atherosclerosis[65]. Atherosclerosis in large vessels can result in severe
thromboembolic events, stenosis or renal failure [66]. Although some researchers claim that
radiation therapy-induced renal arterial stenosis is very rare[67, 68], others have reported severe
stenosis in intrarenal vascular branches[69]. One of the other radiation-induced injuries in the
kidneys is radiation nephropathy[70]. Nephropathy is a kidney disease caused by damages to the
small blood vessels or units in the kidney that are responsible blood filtration[71]. Radiation
nephropathy can happen when a person is exposed to a radiation dose, higher than 5 Grey.
Therefore, radiation nephropathy is possible after a nuclear accident, terrorism or radiotherapy [72,
73]Another sequel of cancer radiotherapy and accidental radiation is radiation-induced renal
fibrosis that is excessive accumulation of collagen and other extracellular matrices (ECM)
components [74-76]. Fibrosis is the hallmark of chronic kidneys diseases and can impair the
function and morphology of vessels [77]. All aforesaid diseases are the result of narrowing of the
blood vessels that is considered as one of the late vascular injuries [66]. Therefore, one of the most
extensively studied side effects of radiation is vascular injuries [78]. However, the focus of most
of these studies is mainly on the cellular and molecular pathology of these diseases and the
computational and mathematical aspects of the effect of radiation on vascular remodeling has not
been thoroughly studied. Nevertheless, it should not go unnoticed that the kidney plays an
important part in blood perfusion, vascular tone, electrolyte control and blood filtration and it has
14

been shown that the correlation between the kidney’s structural heterogeneity and functional
physiology is very strong [79]. Therefore, a computational assessment of vasculature changes in
the kidney due to radiation would help us to understand the pathology of radiation-induced injuries.
In this study, we computationally investigate the earlier effect of radiation, 60 and 90 days after
irradiation, on vessels ≥70 um. With our newly developed method [80] we observed the effect of
irradiation on vessels by measuring the vessel diameter, volume, number of terminal points and
branch depth.
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Chapter 2
Bio-instrumentation
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2. Bio-instrumentation
In this chapter, the hardware-design and upgrade of the in vivo fluorescence imager and
fluorometer are covered. Then the development of the user interface for the in vivo fluorescence
imager and soft-ware upgrade of fluorometer is discussed.

2.1.

In vivo fluorescence Imager

We developed the in vivo fluorescence imager to quantitatively investigate the correlation of
mitochondria metabolism in delayed diabetic wound healing in mice and the effect of Far-red
photo-biomodulation on those wounds.
2.1.1. Hardware upgrade
By using the in vivo fluorescence imager, we imaged the surface fluorescence of cutaneous
wounds to monitor the changes in the concentration of NADH and FAD. To do so, we used an
excitation source with an appropriate wavelength to excite NADH and FAD and optical filters, to
filter the emitted photons from wounds and pass them to a CCD camera. Figure 4 shows a schematic
of the preliminary design of the fluorescence imager. An XYZ translational micro-positioner
(ThorLabs, NJ, USA) is used to manually control the field of view in XY direction. The Z-direction
of the positioner movement controls the working distance and the focus of the images. A mercury
arc lamp (Intensilight, Nikon, Tokyo, Japan) generates the excitation white light and passes it to
the excitation filter wheel (FW103H, ThorLabs, NJ) through a liquid light guide. The excitation
filter wheel has two channels for NADH and FAD. For each channel, the light spectrum is filtered
by optical filters at selected wavelengths to excite the specific fluorophores of NADH and FAD
from the surface of the wounds. We set the excitation filter for NADH at 350 nm (80-nm
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bandwidth, UV Pass Blacklite, HD Dichroic, Los Angeles, CA) and FAD at 437 nm (20-nm
bandwidth, 440QV21, Omega Optical, Brattleboro, VT. On the emission path, another filter wheel
(FW103H, ThorLabs, NJ) is implemented with two channels to pass the emitted photons from
NADH and FAD. The emission filters for NADH and FAD are set at 460 nm (50-nm bandwidth,
D460/50M, Chroma, Bellows Falls, VT) and 537 nm (50-nm bandwidth, QMAX EM 510-560,
Omega Optical), respectively. At the end of the emission path, a charge-coupled camera
(QImaging, Rolera EM-C2, 14 bit) with 1,004×1,002-pixel arrays is used to save the online and
real-time surface fluorescence. Two neutral density filters (ThorLabs, NJ) are also used as
excitation and emission filters for white field channel imaging. We also used a two-channel stepper
motor (BSC202, ThorLabs, NJ) to manually synchronize the rotation of the excitation and
emission filter wheels.

Figure 4: Schematic of the preliminary design of the in vivo fluorescence imager.
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Figure 5

shows the actual implementation of the preliminary in vivo fluorescence imager. Different

parts of it are as follows:
1. The excitation source: Nikon intensilight
2. Filter wheel controller: 2-channle stepper motor
3. Liquid light guide
4. XYZ positioner
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5. Excitation filter wheel

Figure 5: The actual implementation of the preliminary design of the in vivo fluorescence imager.

6. Emission filter wheel
7. Lens: Nikon
8. CCD Camera: Rolera EM-C2
9. PC
To facilitate the use of the in vivo fluorescence imager for other experiments and clinical trials, the
preliminary design of the in vivo fluorescence imager has undergone several improvements. Three
major parts that were changed are the excitation light source, the camera, and the lens. The Nikon
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lens in the preliminary design was changed with a close focus zoom lens from Edmund Optics
(Edmund Optics, Blackwood, NJ, USA). This zoom lens has a higher working distance (from 127
mm to infinity), wide field of view, close focus, and variable apertures, to adjust the depth of field,
making the user needless of XYZ micropositioner. On this account, just by changing the settings
on the zoom lens, the user can zoom and focus on the desired area without any need for position
change of the experimental model or the patient. Moreover, Edmund lens ($ 613) is much cheaper
in terms of cost compared to the previous Nikon lens ($ 5000). By replacing the Nikon lens with
Edmond lens, while reducing the cost of prototype assembly, the resolution of the images is saved.
Another fundamental change is related to the replacement of the excitation source. Instead of using
a lamp as the excitation light source with white light and an excitation filter wheel, we used
fluorescence LED illumination, Xcite LED1 (Excelitas Technologies Corp., Waltham, MA, USA)
with four switchable wavelengths, due to many reasons, including:
Speed: The interchangeable excitation filters integrated for each LED modules is designed to
allow accelerated wavelength switching beyond the scope of motorized filter wheels. Saving time,
by reducing the imaging process of all three channels from 10 minutes to less than 5 minutes.
Phototoxicity: Preliminary studies show that the cells manifest less phototoxicity after imaging
with LED versus mercury lamps. Therefore, the possible errors in the redox ratio caused by
mercury arc lamp are reduced.
Lower cost: Using LEC decreases electrical consumption by 69%, reducing the operating costs.
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Environment green: It would greatly help the environment for two reasons. One, the light source
does not contain mercury and two, energy consumption is reduced by 84%.

Figure 6: The schematic of the upgraded in vivo fluorescence imager.

One of the other main changes is the replacement of the Rolera camera with Retiga R6. Retiga R6
with a pixel array of 2688×2200, 16-bit and higher field of view, increased the resolution and
dimensions

of

acquired
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images.

Figure
6

shows the schematic of the upgraded in vivo fluorescence

imager.

In this design, since Xcite LED1 provides us with the excitation wavelengths for exciting NADH
and FAD, the excitation filter wheel is removed, and by that means, just the emission filter wheel
needs a controller. As a result, we replaced the two-channel stepper motor with a lighter and
smaller one-channel stepper motor (BSC201, ThorLabs, NJ).
The in vivo fluorescence imager is designed to image the surface fluorescence of a tissue. The
tissue can be on any part of a patient body. In the case of diabetic wounds, the diabetic ulcers are
on the low-extremity of patients. To facilitate the imaging process and to minimize the movement
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of the patient, we needed to be able to rotate the fluorescence imager so the patient would not have
to experience any discomfort from changing their position. Therefore, the optical parts of the
fluorescence imager were separated from the hardware parts and put in two different boxes. Box
“a” containing the liquid light guide, emission filter wheel, lens and camera, and box “b” contains
the

excitation

source

and

filter

wheel

controller.

Figure 7 is showing these two boxes, attached with a bar, allowing the optical parts to rotate
separately from the rest of the instrument and image tissues on different parts of a body.
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Figure 7: The overview of the in vivo fluorescence imager.

Figure 8

shows the internal design f box “a” and “b”, containing:
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1. Excitation source: Xcite LED1

Figure 8:The actual implementation of the upgraded in vivo fluorescence imager.

2. Filter wheel controller: 1-channel stepper motor
3. Liquide light guide
4. Fiber adapter
5. Emission filter wheel
6. Edmond zoom lens
7. CCD camera: Retiga R6
8. Laptop
With these changes applied to in vivo fluorescence imager, not only it has become more user
friendly but also the size and weight have been significantly reduced making it easier to move.
Moreover, the ability to rotate the optical part of the instrument accommodates the patients with
the ease of positioning.
26

2.1.2. User interface development
One of the significant improvements for the in vivo fluorescence imager was developing a user
interface using LabVIEW (2019 National Instruments). Two user interfaces were developed for
the design with two filters and the design with one filter wheel and the Xcite LED as the excitation
source. However, to make it brief, only the user interface that is developed for Xcite LED will be
discussed.
This user-interface atomizes the synchrony of excitation light with the proper emission filter. Also,
it enables the user to choose an arbitrary exposure and a path for saving images. The user interface
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reduced the time of experiments from 5 minutes to less than 1 minute.

Figure 9 shows the control panel of the

in vivo fluorescence imager. Seven parts of the control panel

are boxed and numbered. Box 2 of the control panel shows a red LED representing the current
camera temperature. This LED indicates the camera has reached the regulated temperature lock
when it turns green. Before running the program, the proper COM should be inserted in box 1.
Users receive or give the information from each box of the control panel as follows:
1. Insert the COM to start communicating with the device and run the program.
2. Wait for the LED to turn green.
3. Click on the channel you want to image.
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4. Enter the path you want the image to be saved for each channel.

Figure 9: The in vivo fluorescence imager user interface control panel.

5. Set the exposure for each channel.
6. Click on the “Save” button to save the image.
7. Click on the “Exit” button when the experiment is over to turn off the device.
After running the program, a window will pop up showing live video (on-line and real-time) of
the tissue. The exposure for each channel is predefined and as explained before, the user can set
the desired exposure from box 5. By clicking on each of the channels in part 3, the selected channel
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will be highlighted by blue in the control panel and excitation wavelengths will change
accordingly. The emission filter wheel will also rotate to synchronize the excitation wavelength
and optical emission filter. The path that images are saved is predefined too. User can save the
images from each channel in an arbitrary path by entering the desired path for each channel in part
4 and then click on the “Save” button. It is important to mention that by clicking on the “Save”
button, an image from what the camera is displaying at the moment will be saved. To save the
images from other channels, the user should click on the desired channel from part 3 and then click
on the “Save “button again. The overall flow chart for the user interface is shown in .
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Figure 10: Overall flow chart of in vivo fluorescence imager user-interface

The "Channel Picker" predefined process is executed every time the user selects a channel from

box 3.
Figure

11shows

the

flow

chart

of
31

the

“channel

picker”.

As

Figure
11shows,

the in vivo fluorescence imager is calibrated on the white field and if the user runs the

program, the camera shows white field footage of the tissue. By selecting other channels, the
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excitation source and the filter wheel will change accordingly and the NADH and FAD footages
of tissue will be displayed.

Figure 11: The “Channel Picker” predefined process flow chart.
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Figure 12 shows the flow chart of the “Save” predefined process. The saving path will change

Figure 12 : The “Save” predefined process flow chart.

accordingly by selected channels from box 3.
2.1.3. Linearity test of in vivo fluorescence imager
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This test is performed to assess the linearity response of the system. Cuvettes containing dilution
of NADH and FAD fluorescent dyes (Sigma-Aldrich Inc., St. Louis) were imaged. The
concentrations were chosen based on tissues’ physiological relevant range [81].The mean ±
standard deviation (SD) of the images is calculated, and linear regression is performed (

Figure 13). For correlations between measurements, a Pearson correlation coefficient was
determined.
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Figure 13a shows that the NADH channel of fluorescence imager is linear with the changes in the
concentration

of

NADH

(R2=0.98,
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P<0.001),

while

in

Figure 13b, the intensity of the captured NADH images remained constant with FAD concentration
variations. These results suggest that the NADH channel is sensitive to NADH solely, and it is
unresponsive to FAD concentration variations. Similarly, by increasing the concentration of FAD
in

the

solutions,

the

intensity

of

captured

37

FAD

images

increases

linearly

(

Figure 13c, R2=0.98, P<0.001), and the intensity of NADH images remained constant (
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Figure 13d). Therefore, the fluorescence imager used in our study is linear in the biologically
relevant concentrations of NADH and FAD, and there is no cross-relation between the two
channels. Furthermore, it can be inferred that the intensities of the cryo-images correlated linearly
with the amount of the autofluorescence signal from the samples.
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Figure 13) The results of the linearity test for the fluorescence imager using exogenous NADH and FAD
solutions: the NADH (a) and FAD (b) response of the system to the increase in NADH concentrations. The
NADH (c) and FAD (d) response of the system to the increase in FAD concentrations. The fitted linear regression
is shown as a line, and the R2 values are included in the legends. The in vivo fluorescence imager used in our
study is linear in the biologically relevant concentrations of NADH and FAD, and there is no cross-relation
between the two channels. NADH, nicotinamide adenine dinucleotide; FAD, flavin adenine dinucleotide

2.2.

Fluorometer

A complete description of the implementation and the design of the fluorescence imaging system
can be found in our previous study [82, 83]. The fluorometer is a fiber-optic-based optoelectronic
fluorometer, designed and developed in the Biophotonics lab. It is used to monitor the
concentration of autofluorescence electron carrier, NADH and FAD. The fluorometer is equipped
with two synchronized filter wheels, a bifurcated fiber optic bundle, and one photomultiplier tubes
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(PMT) for signal detection in NADH and FAD channels. The filter wheels communicate with the
computer through a control box (Lambda- 3, Sutter instrument, CA). The bifurcated fiber bundle
consists of high-grade fused silica fibers for UV transmission (Newport instrument, NJ) with a
distal end of 3 mm inner diameter. For fluorescence spectroscopy, the peak energy of the NADH
and FAD excitation spectrum occurs at 365 nm and 436 nm, respectively. The emission filters for
NADH and FAD fluorescence are set at 455nm and 525nm, respectively. The fluorometer was

Figure 14: The schematic of fluorometer (a) and previous actual implementation (b) of the fluorometer.

41

used to acquire surface fluoresce signals from NADH and FAD by placing the fiber optic probe
against the desired tissue.

Figure 14 shows the schematic and the previous actual implementation of this device.
2.2.1. Hardware Upgrade
The light source in the previous design of the fluorometer was a mercury arc lamp (Intensilight,
Nikon, Tokyo, Japan). Due to reasons such as speed, phototoxicity, environmental green and lower
cost that is discussed in detailed before (2.1.1), we replaced the light source by Xcite LED1
(Excelitas Technologies Corp., Waltham, MA, USA) with 4 switchable wavelengths.
2.2.2. User interface upgrade
A LabVIEW user interface was developed for fluorometer, to control PMT gain, filter wheel
synchronization, and data acquisition. However, this user interface was not able to communicate
with Xcite LED1. Therefore, we developed a LabVIEW subVi called XLED and implemented it
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in the original LabVIEW program and changed the main code so it would be able to communicate
with Xcite LED. However, to concise, only the XLED subVi will be discussed.

Figure 15a

Figure 15b

the

shows the overall background code of XLED subVi. The “Numeric” icon in

defines whether a signal is received from NADH or FAD. It gets this information from
icon

“i”
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show

in

Figure 15c

from the main code. “i” is the number of iteration (the number of times that the while

loop in the main program has been executed). In each loop, the filter wheels rotate to go to the
location of either FAD or NADH and this information is passed on to XLED Vi through the
“Numeric”

Figure 15d

icon.

shows a True or False Case Structure in LabView. This structure will send the orders

from the “False” Case Structure if the excitation source is set to excite NADH and it will send the
orders from “True” if the excitation source is set to excite FAD. "Visa Write" and "Visa Read" in
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Figure 15e

will execute the commands that have been produced in the case structure to turn the
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desired XLED light sources off and on. Part 1 in figure 15.e will turn the undesired excitation light
off and part 2 will turn the desired excitation light on.

Figure 15: Background cod of XLED SubVi.
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Figure 16 is showing

the upgraded front panel for the fluorometer. Part 1 in figure15 is added to the

front panel so Xcite LED1 will communicate with the PC.

Figure 16: The upgraded control panel for the fluorometer.
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Chapter 3
In vivo and 3D fluorescence imaging
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3. In vivo and 3D fluorescence imaging
In what follows, the result of our study on the effect of 670 nm photo-biomodulation on diabetic
mice wounds, using the in vivo fluorescence imager is discussed. As explained before, the
excitation light source in the second version of the in vivo fluorescence imager is Xcite LED1
(Excelitas Technologies Corp., Waltham, MA, USA). Xcite LED1 excites the autofluorescence
coenzymes of the surface of the wounds, NADH and FAD, through a fiber-guiding light. Xcite
LED1 produces the appropriate excitation wavelength for NADH and FAD with a peak at 385 nm
and 460nm, respectively. The emitted light from the wounds passes through a set of optical filers
inserted in a filter wheel. NADH and FAD emission filters were set at 460 nm (50-nm bandwidth)
and 537 nm (50-nm bandwidth), respectively. A neutral density filter (ThorLabs, NJ) was also
used as the emission filter for white field imaging. A single channel stepper motor was used as the
filter wheel controller to synchronize the produced excitation light with the appropriate emission
filter. Finally, a charged charge-coupled device (CCD) camera (QImaging, Retiga R6) captures
the filtered emitted light and save the result as a .tiff file.

3.1.

In vivo fluorescence imaging of diabetic wounds

The objective of this study is to investigate the effect of far-red photo-biomodulation (PBM) on
the wound healing process by tracking the changes in the ratio of the mitochondrial bioenergetics
(NADH /FAD) or redox ratio (RR).
Wound healing is a complex and dynamic biological process that involves overlapping phases of
hemostasis, inflammation, proliferation, and remodeling [84]. Excessive and uncontrolled
oxidative stress has been shown to contribute to a perpetual inflammatory state, deregulate the
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healing process; thus, playing a central role in the pathogenesis of chronic non-healing wounds
[55, 85]. Photobiomodulation (PBM) by far-red (FR) to near-infrared (NIR) light has been
demonstrated to accelerate diabetic wound healing in preclinical and clinical studies. FR/NIR
photons interact with the mitochondrial photo-acceptor molecule, cytochrome c oxidase (CcO),
the terminal electron acceptor of the electron transport chain (ETC) [86, 87]. This interaction
modifies NADH linked dehydrogenase reactions [88] and alters the rate of ADP/ATP exchange.
[89], resulting in improved mitochondrial bioenergetics and activating intracellular signaling
pathways that decrease chronic inflammation and promote healing [90]. Imaging NADH and FAD,
two autofluorescence mitochondrial metabolic co-enzymes, is one of the methods vastly used to
study mitochondria bioenergetics. Our in vivo fluorescence imager enables us to capture the realtime metabolic images (by capturing the surface fluorescence of NADH and FAD) of the
wounds in vivo. The redox ratio (NADH/FAD) serves as a quantitative indicator of the
mitochondrial redox state [31, 44, 91]. In the current study, the fluorescence imager is utilized to
test the hypothesis that PBM would accelerate the healing process in the db/db mice model of
diabetes by affecting the mitochondrial redox state.
3.1.1. Experimental Protocol
The conducted experiments were approved by the Institutional Animal Care and Use Committee
(IACUC) at the University of Wisconsin Milwaukee. Genetically diabetic mice (db/db−/− mice;

BKS.Cg-Dock7m +/+ Leprdb/J), 8 weeks of age were obtained from Jackson Laboratories (Bar
Harbor, ME) and used in this study. After confirming a hyperglycemic state, the mice went through
wound induction surgery. A 10 mm full-thickness excisional wounds were generated on either side
of the mouse's midline at the level of the shoulders using a disposable sterile 4 mm biopsy punch
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and iris scissors. General anesthesia was induced using 4% isoflurane in 100% oxygen (flow rate
1 L/min), and the anesthesia was maintained using 1–3% isoflurane during the surgery.
Light treatment of the induced wounds was performed using 670 nm LED arrays engineered to
eliminate heat (670±10 nm GaAlAs LED arrays (75 cm2), Quantum Devices, Barneveld, WI).
Diabetic db/db mice were randomly assigned to 670 nm PBM (FR-PB, n=6) or sham treatment
(Sham group, n=5) groups. Treatment consisted of positioning the 670 nm LED array 1–2 cm
directly above the wound surface and irradiating the wound for 90 seconds at an irradiance of 60
mW/cm2 once per day for five days per week to deliver a dose (radiant exposure) of 4.5 J/cm2 at
the wound surface for each treatment. Sham-treated mice had the LED array positioned above the
wound for 90 seconds, but the LED array was turned off.
3.1.2. Time-line and tissue preparation
A total of 16 diabetic mice were involved in this investigation, all of which went through the
wound induction surgery. Except for 5 of them that were sacrificed after collecting biopsies for
cryo-imager (3.2.1.1), the rest (a total of 11) received far-red Photobiomodulation treatment and
were imaged by the in vivo fluorescence imager. In vivo fluorescence imaging was performed on
days 0, 3, 6, and 9 post-wounding on the remaining group of mice (n=6 FR-PBM, n=5 shamtreated). The imaging of wounds was performed right after receiving the 670 nm
photobiomodulation. Therefore, there was no interference of PBM in the imaging procedure, and
the NADH and FAD excitation/emission did not interfere with the effect of 670 PBM on the wound
healing process.
3.1.3. Image processing
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The image processing was performed using MATLAB. Using the in vivo fluorescence imager,
images of the wounds on diabetic mice were acquired from white field, NADH and FAD channels.
First, to minimize the day-to-day variation of light intensity, the NADH and FAD images were
calibrated by images of two cuvettes containing 50μM NADH and 0.5μM FAD solutions,
respectively. Second, the white filed images were used to determine the outline of the wounds, and
then it was masked on the images from NADH and FAD channels. Then, the redox ratio of the
wounds (RR = NADH/FAD) was calculated pixel by pixel. The mean of RR histograms was
considered as the quantitative marker, called Surface RR and it is calculated by using Equation1.
𝑅𝑅 =

1
𝑁

∑(𝑤𝑜𝑢𝑛𝑑 𝑝𝑖𝑥𝑒𝑙𝑠)

Equation 1

The wound area can be approximated by the number of wound pixels multiplied by pixel size and
by using Equation 2 we can calculate the normalized wound area.
𝑃𝑆(𝑡)×𝑁(𝑡)

𝑁(𝑡)

𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑊𝑜𝑢𝑛𝑑 𝐴𝑟𝑒𝑎 = 𝑃𝑆(0)×𝑁(0) = 𝑁(0)

Equation 2

Where N(t) is the number of wound pixels at day t. N(0) is the number of wound pixels at day 0,
i.e., the initial wound area. PS(t) is the pixel size at day t, and PS (0) is pixel size at day 0. Since
the pixel size remained unchanged, we can remove it from the denominator and nominator. This
simplifies the equation, so the normalized wound area is equal to the number of pixels at day t to
the number of pixels at day zero.
3.1.4. Results

52

Figure 17 shows the on-line temporal fluorescent redox images of FR-PBBM and Sham treat
groups

on

days

0,

3,

6

and

9

of

53

the

experiment.

The

data

in

Figure 17 at days 6 and 9 show that the RR in the FR-treated wounds is greater than the RR
measured in sham-treated mice. This reflects an increase in NADH and a decrease in the FAD
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concentrations of the FR-treated wounds over time, resulting in a visibly greater RR at days 6 and
9.

Figure 17: Representative in vivo fluorescence images of NADH, FAD, and the tissue redox ratio
(NADH/FAD) for representative wounds over days: unlike the wound on the sham-treated mice, the FR-PBM
treatment increased the NADH intensity of the wounds and decreased the FAD intensity. Therefore, at days 6 and
9 of post wounding, the wound on FR-PBM mice showed a higher redox ratio in comparison with sham-treated
mice. NADH, nicotinamide adenine dinucleotide; FAD, flavin adenine dinucleotide; FR, far-red; PBM,
photobiomodulation.

Table 1 presents the data and the statistical analysis for FR-PBM and sham-treated groups of mice
over the time course of the experiment. Surface RR and wound area were obtained using in vivo
fluorescence imager, and their corresponding changes over time are the RR change rate and closure
rate, respectively. In more detail, The RR change rate is the difference between the mean RR of
samples in two consecutive data collection days. This biomarker is used to evaluate the temporal
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differences in the in vivo RR changes at different days. A negative value of the RR change rate
corresponds to a descending trend in the RR, i.e., a drop in the RR by a decrease in mitochondrial
redox state and an increase in oxidative stress. The wound closure rate was defined as the
difference in wound area between two consecutive data collection days and was used to determine
the rate of wound healing. The closure rate provides a quantitative index of wound healing over
time. A positive value in the closure rate corresponds to a decrease in the wound area, and a
negative value of the closure rate corresponds to an increase in the wound area.
FR-treatment resulted in a notable increase in Surface RR at days 6 and 9, but the change rate of
surface RR became significant by day 9. Thus, over the time course of the experiment, the
mitochondrial redox state of the wounds in the FR-PBM group increased at a faster rate than the
sham-treated group.
Table 1 : Quantitative assessment of FR-PBM (in vivo): the surface RR, RR change rate, normalized wound area, and
closure rate are calculated by in vivo fluorescence imager.

Surface RR
RR change
rate
Normalized
wound area
Closure rate

3.2.

Day0

Day3

Day6

Day9

FR-PBM
Sham
FR-PBM

1.01 ± 0.07
1.08 ± 0.07
-

0.46 ± 0.03
0.47 ± 0.05
-0.54 ± 0.07

0.55 ± 0.05*
0.36 ± 0.06
0.09 ± 0.05

1.26 ± 0.07*
0.67 ± 0.04
0.71 ± 0.08*

Sham
FR-PBM

1

-0.61 ± 0.11
0.87 ± 0.08*

-0.05 ± 0.06
0.82 ± 0.02*

0.25 ± 0.04
0.61 ± 0.09*

Sham
FR-PBM

1
-

1.32 ± 0.14
0.13 ± 0.08*

1.26 ± 0.09
0.05 ± 0.06

1.08 ± 0.11
0.21 ± 0.11

Sham

-

-0.32 ± 0.14

0.06 ± 0.10

0.18 ± 0.11

3D fluorescence Cryo-imager

3D fluorescent cryo-imager was custom-designed at Biophotonics Lab, University of Wisconsin
Milwaukee. This instrument has been described in detail in our previous studies [31, 32, 48].This
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device captures the metabolic state of the tissue at the cryogenic temperature. The system has a
mercury arc lamp as the excitation light source (200 W lamp, Oriel, Irvine, CA, in the light source
from Ushio Inc., Japan). The light passes through a filter wheel, which has NADH (350 nm with
80 nm bandwidth) and FAD (437 nm with 20 nm bandwidth) optical filters. The light is air-guided
toward the sample, and emitted light passes through the emission filter wheel, which contains the
specific emission filters for NADH (460 nm with 50 nm bandwidth) and FAD (537 nm with 50
nm bandwidth). Then, the images will be acquired using a CCD camera (QImaging, Aqua) from
the filtered emitted photons. A microtome blade cuts through the sample with a specified thickness
(varies based on each study), and the images are captured sequentially.
3.2.1. Metabolic imaging of Diabetic wounds
3.2.1.1.

Experimental Protocol:

A total of 16 diabetic mice were involved in this study, all of which went through wound induction
surgery. Five of them were sacrificed immediately after biopsies of wounds for cryo-imaging at
day 0 were collected. The harvested wound samples were flash frozen. Moreover, at the end of the
experimental protocol, on day 9 of post-wounding, the entire wounds were excised and snapped
frozen immediately. All 16 frozen biopsies were then imaged by cryo-imaging for the volumetric
redox study.
3.2.1.2.

Image processing:

The cryo-images were processed using MATLAB. NADH and FAD images were calibrated with
images captured from a flat field for NADH and FAD channels, respectively. The background
(low-intensity) voxels were set to zero, and 3D redox images were obtained by calculating the RR
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for each voxel. The mean of RR histograms was considered as the quantitative marker, called
Volumetric RR.
3.2.1.3.

Results:

Figure 18a shows representative 3D rendered cryo-images captured from the biopsies collected at
the beginning and the end of the experimental protocol. The color-coded images of wound biopsies
show higher NADH and lower FAD in the FR-PBM group in comparison with the sham-treated
group,

resulting

in

a

RR.
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higher

volumetric

Figure 18b illustrates the histograms of the corresponding RR images, as shown

in
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Figure 18a. The histogram of sham-treated wounds at day 9 has shifted to the left when compared
to the day 0 wound histogram. Also, it shows that the histogram of sham-treated wounds at day 0
and FR-PBM wounds at day 9 are centered almost at the same place, but the histogram of FRPBM is more widely distributed. It means in the wounds of the day-0 sham-treated group; the
redox ratio was more uniform over the wound biopsies. However, the redox ratio in the wounds
of the day-9 FR-PBM group is unevenly distributed over the wounds. It can suggest that although
by day 9 the FR-PBM wounds are manifesting successful wounds healing, to observe better results,
receiving more dosage of FR-PBM might be needed. The mean volumetric RR ± standard
deviation

in

three

groups

of

wounds

is

shown

in
Figure 18c. The Volumetric RR of sham-treated wounds on day 9 significantly dropped by 33%
when compared to the sham-treated mice on day 0. Also, FR-PBM caused a significant 46%
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increase in the volumetric RR of wounds on day 9 when compared to the sham-treated wounds on
day 9. This observation confirms the data that was obtained from the in vivo fluorescence imager.

Figure 18: The cryo-imaging results of sham-treated vs. FR-PBM treated wounds. (A) Representative
fluorescence cryo-images of NADH, FAD, and the tissue redox ratio (NADH/FAD) for representative wounds
are shown at days 0 and 9. (B) The redox ratio histogram of the wounds on the FR-PBM and sham-treated mice.
(C) The volumetric redox ratio ± standard deviation of representative wounds in bar plots. The wound on FRtreated mice showed a 46% higher redox ratio in comparison with sham-treated controls at day 9 [n=5 shamtreated (day 0), n=5 sham-treated (day 9), and n=6 FR-PBM (day 9)]. *, significant difference between day 0 and
day 9 in redox ratio of sham-treated wounds. **, significant difference between redox ratio of FR-PBM treated
vs. sham treated wounds at day 9 of post wounding. NADH, nicotinamide adenine dinucleotide; FAD, flavin
adenine dinucleotide; FR, far-red; PBM, photo-biomodulation.

3.2.1. Vascular imaging validation:
A 3D vascular detection and segmentation method using autofluorescence imaging was developed
in our lab, termed VMI, short for “Vascular-metabolic Imaging”. In this method, the NADH and
FAD images that are acquired by cryo-imager to study the metabolic state of an organ are also
used to extract its 3D vessel network. The intrinsic NADH and FAD fluorophores illuminate the
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foreground of each image, which makes the background vessel networks more distinctive. We
hypothesized that the dark voxels are associated with the vasculature because the red blood cells
quench the auto-fluorescence signals from NADH and FAD [92]. To validate this method, we
coregistred the VMI vessel images with the vessel images extracted from red fluorescence images
of a genetically modified rat kidney (TdTomato) with tagged endothelial cells. We also showed
that the extracted vessel networks using VMI follows Murray’s law. Murray’s laws state that when
a parent blood vessel branches into daughter blood vessels, the cube of the radius of the parent
vessel is equal to the sum of the cubes of the radii of daughter blood vessels. This relation is
presented in Equation 3, where 𝑟𝑝 is the diameter of parent vessel lumen and 𝑟𝑑 is the diameter of
the daughter vessel lumen and 𝑖 is the number of daughter vessels of a parent vessel.
3
𝑟𝑝3 = ∑𝑁
𝑖=1 𝑟𝑑𝑖

Equation 3

This law is based on the assumption of constant blood flow and a hypothesis that throughout the
vascular system, the sheer force of moving blood on the inner wall is constant. Murray derived
this law from a minimum work hypothesis by defining a cost function for the sum of the energy
cost of blood in a vessel and the energy cost of pumping blood through the vessel. If vessel radii
follow the Murray law, the cost is minimized [93].
Using cryo-imager, the TdTomato transgenics rat kidney was imaged in two channels of
fluorescence, NADH (excitation 545, emission 645), and red (excitation 545,147 emission 645).
The 3D kidney vessel network of TdTomato rat was extracted from both red fluorescence vessel
elements of red channel images and dark vessel element of the NADH channel. To apply Murray’s
law on the extracted vessels, we used the branch depth as an indicator to differentiate a parent
vessel from a daughter vessel. Branch depth is the number of bifurcations in the shortest path, from
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the beginning point to a given point in the vessel network. Branch depth increases every time a
bifurcation happens in a branch. Equation 4 shows Murray’s law based on the branch depth.
3
𝑟𝑘3 = ∑𝑁
𝑖=1 𝑟𝑘+1𝑖

Equation 4

Where 𝑟𝑘 is the diameter of a vessel at depth of 𝑘 (parent vessel) and 𝑟𝑘+1 is the diameter of
daughter vessel at depth of 𝑘 + 1 and 𝑖 is the number of daughter vessels at depth of 𝑘 + 1 and
𝑖 is the number of daughter vessels at depth 𝑘 + 1.

Figure 19 shows the result of applying Murray’s law on branching of extracted vessel structures
from both NADH and red 3D channels. The VMI Data colored with green is showing the vessel
extracted from NADH channel images and the Red Data colored with red is showing the vessels
extracted from the red channel images. According to Murray’s law, the relationship between the
cubed diameter of the parent vessel and summation of the cubed diameter of the daughter should
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be fitted to y = x, i.e., a line with a slope of 1 and y-intercept of 0. Using linear regression, two
lines are fitted to each set of data points. The intercept for both lines is approximately zero and the
slopes for VMI and red channel are close to 1, indicating that the VMI branching, similar to red
vascular branching follows Murray’s law successfully.

As
Figure 19 shows, although the slope of fitted lines to data sets of NADH and red channels are close
to 1, there is still an error that needs to be discussed. Besides the human artifact and the device
artifacts, this error might be induced due to a simplification that we used in defining the parent
vessel and daughter vessel. Murray’s law works more accurately in the branches where the angle
of bifurcation is at least 75 degrees. However, to simplify our calculations, we disregarded the
angle of bifurcation and simply assumed that wherever a bifurcation happens the daughter vessels
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Figure 19: VMI follows Murray’s Law. The parent vessel diameter cubed is plotted against the sum of the
diameter cubed of their corresponding daughter vessels. The data from red fluorescence of TdTomato rat are
shown as red circles, and the data from vasculature extracted using the VMI technique are represented as green
stars. Two vascular branching data from VMI and red fluorescence have merged, and their linear regression fit
has shown very good compliance with Murray’s law (identity line, y=x).

are separated from the parent vessels. However, this simplification does not invalidate our method,
it just imposes an error on our calculations.
3.2.2. Kidney radiation-induced vascular injury
3.2.2.1.

Experimental protocol

The animal protocols were approved by the Institutional Animal Care and Use Committees
(IACUC) at the Medical College of Wisconsin, Milwaukee. WAG/RijCmcr female rats were
irradiated at 12-13 weeks of age (~155 grams). Two groups of rats were randomized. I) nonirradiated (n=12); II) 12.5 Grey leg–out partial body irradiated (leg-out PBI) (n=14). The 12.5
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Grey leg–out partial body irradiation (PBI) protocol in rats was the same as that reported in
previous studies [94]. Briefly, rats were restrained and irradiated without the use of anesthetics.
One hind limb of each rat was carefully externalized and shielded with a 0.25-inch lead block. An
XRAD 320KV orthovoltage x-ray system (Precision X-Ray, North Branford, Connecticut) was
operated at 320 kVp and 13 mAs with a half-value layer of 1.4 mm Cu with a dose-rate of 1.75
Grey min-1 for a total dose of 12.5 Gy. Radiation was delivered posterior to anterior to the rat.
The dosimetry is as described by Medhora et al [95]. Groups of rats were euthanized either at 60
or 90 days after radiation and kidneys were harvested then flash frozen in prechilled isopentane.
In total four groups of rats were studied, rats receiving 0 Grey radiation harvested at day 60 (n=6)
and day 90 after radiation (n=6), rats receiving 12.5 Grey radiation harvested at day 60 (n=7) and
day 90 after radiation (n=7).
3.2.2.2.

Vascular quantification and segmentation

For this study, we used the optical Cryo-imager to obtain the anatomical vessel structure of
kidneys. The Vascular segmentation method is described in detail in our previous study [80].
Briefly, the stack of images acquired from the NADH channel of Cryo-imager goes through a set
of image processing steps. First, the brightness and contrast of each slice are adjusted to enhance
the quality of the image and to bold the vasculature elements. Second, the images are inverted
because the blood in the vessels quench the NADH fluorescence and leaves the tissue itself bright
but makes the inside the lumen of vessels darker (more like a negative image). Third, the
background is subtracted so the other components of kidney tissue are removed from the kidney
vessel tissue. Then by stacking the slices of each sample in Z-direction the re-constructed 3Dvasculature is obtained.
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For quantification purposes, the 3D-vasculature is fed to Imaris (9.5.1 software, Bitplane Inc) and
using a manual tracing algorithm based on local intensity contrast, the vessel network is extracted.
The diameter of each vessel using both automatic and manual method is set. In the end, based on
the extracted vessel network, Imaris calculates different parameters such as vessel mean diameter,
vessel volume, the vessel branch depth, the number of terminal points etc. To measure the vessel
density, the volume of each sample was measured by detecting the surface of the whole kidney in
Imaris. Then the total vessel volume was divided by the whole sample volume to obtain vessel
density.

3.2.2.3.

Results

The representative 3D extracted vasculature, the vessel terminal points (green spheres) and
beginning points (blue spheres) from four groups of rats are shown in Figure1. The size of spheres
marking the beginning of the vessel and its terminal points varies based on the vessel diameter at
that point. Figure 20a, b, c, and d represent the day-60 non-irradiated, day-60 irradiated, day-90
non-irradiated, and day 90-irradiated kidneys, respectively. Figure 20 shows that the green spheres
in Figure 20b and d are both smaller and lower in number in comparison with Figure 20a and c,
respectively. This indicates that either, small vessels are lost due to radiation or the vessels have
become smaller and the number of vessels that could be detected 60 and 90 days after receiving
12.5 Grey radiation has decreased. With a closer look at the samples in Figure 20, it can be
perceived that radiation has also lessened the diameter of the vessels. Also, the effect of radiation
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is more evident in figure 1d in comparison with figure 1b meaning that the changes in vasculature
due to radiation is more distinct 90 days post-radiation in comparison with 60 days post-radiation.
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Figure 21

makes the observations in Figure 20 more tangible since it is color-coded based on the

mean diameter of dendrites (vessels) ranging from 70 µm to 850 µm. The diameter of each vessel
is measured from the center to the surface of the vessels. Violet is assigned to the vessels with a
diameter close to 70 µm and red is assigned to the vessel diameter close to 850 µm. Representative
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non-irradiated and irradiated kidneys harvested 60 days post-radiation are shown in
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Figure

21and
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b.

Figure 21c and d are representative kidneys for non-irradiated kidneys and irradiated kidneys harvest

at

day-90

post-radiation.
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Figure 21a

closer

and c show that in non-irradiated kidneys, bigger vessel branches (the vessels that are

to

the

beginning

point)

are

mostly
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colored

red

or

yellow.

However,

Figure 21b

and d show that the bigger vessel branches are mostly colored green or blue. It denotes

that radiation can damage the vessels, making the lumen of the blood vessels smaller. the
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comparison

of

vessel

75

colors

in

Figure 21a

harvested

and b can infer that vessel mean diameter in non-irradiated and irradiated kidneys
60

has

not

changed

noticeably.
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However,

the

comparison

of

Figure 21c

and d show that by 90 days post-radiation, vessel diameter in irradiated kidneys is

remarkably different from that of non-irradiated kidneys.
Figure

22

shows

the

same

kidneys
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in

Figure

20

and

Figure 21

but color-coded based on the branch depth. Branch depth is the number of bifurcations in

the shortest path, from the beginning point to a given point in the vessel network. The maximum
branch depth is an indicator of the maximum number of times a vessel has been bifurcated to get
to the smallest detected vessels. Maximum branch depth can be an indicator of the effect of
radiation on small vessels. the decrease of maximum branch depth can be interpreted in two ways.
One, small vessels are lost due to radiation or two, the small vessels have become smaller so that
they were not detectable with resolution of 70 µm. The highest maximum dendrite (vessel) branch
depth that was observed in the samples was 19. Therefore, vessels are colored from the branch
depth of 0, colored by violet, to the branch depth of 19, colored by red. Figure 22a and b are
representative of the non-irradiated and irradiated kidneys harvested day-60 post-radiation. The
smaller vessels (the vessels closer to the endpoints) in these figures are colored mainly blue and
green. It suggests that first, the maximum branch depth for both groups of irradiated and nonirradiated kidneys harvested 60-days post-radiation is less than 19 and second, the branch depth
has not been considerably affected by radiation 60 days after radiation. In contrast, in Figure 22c
we can see that the color of smaller vessels is yellow and sometimes orange and red, but in Figure
22d they are green and blue. It means that radiation has affected the maximum of the vessel branch
depth and this effect is conspicuous by day-90 post-radiation.
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Figure 20: The representative extracted 3D vasculatures in which the terminal points of each vessels is marked
with green spheres and the vessel beginning point is marked with blue sphere. a) Kidney received 0 grey
irradiation and was harvested 60 days after irradiation. b) Kidney received 12.5 grey irradiation and was harvested
60 days after irradiation. c) Kidney received 0 grey irradiation and was harvested 90 days after irradiation. d)
Kidney Received 12.5 irradiation and was harvested 90 days after irradiation.
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Figure 21:The representative extracted 3D vasculatures colored-coded based on diameter. The vessel
diameter ranges from 70 µm to 850 µm. The biggest vessels are colored red, and the smallest vessels are colored
violet. a) Kidney received 0 grey irradiation and was harvested 60 days after irradiation. b) Kidney received 12.5
grey irradiation and was harvested 60 days after irradiation. c) Kidney received 0 grey irradiation and was
harvested 90 days after irradiation. d) Kidney Received 12.5 irradiation and was harvested 90 days after
irradiation.
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Figure 22: The representative extracted 3D vasculatures colored-coded based on branch depth. The branch
depth ranges from 0 to 19. Vessels with branch depth of 0 are colored violet and vessels with branch depth 19 are
colored red. a) Kidney received 0 grey irradiation and was harvested 60 days after irradiation. b) Kidney received
12.5 grey irradiation and was harvested 60 days after irradiation. c) Kidney received 0 grey irradiation and was
harvested 90 days after irradiation. d) Kidney Received 12.5 irradiation and was harvested 90 days after
irradiation.
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To analyze the time-repose the fold change was used for the total vessel volume, vessel density,
vessel branch depth and the number of terminal points, 60 and 90 days after radiation. The formula
that was used for fold change is as follows:
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑝𝑎𝑟𝑎𝑚𝑒𝑡𝑒𝑟 𝑖𝑛 𝑑𝑎𝑦−90 𝑝𝑜𝑠𝑡 𝑟𝑎𝑑𝑖𝑎𝑡𝑖𝑜𝑛 𝑖𝑟𝑟𝑎𝑑𝑖𝑎𝑡𝑒𝑑 𝑘𝑖𝑑𝑛𝑒𝑦𝑠

𝐷𝑎𝑦 90 𝑓𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒 = 𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑝𝑎𝑟𝑎𝑚𝑒𝑡𝑒𝑟 𝑖𝑛 𝑖𝑛 𝑑𝑎𝑦−90 𝑝𝑜𝑠𝑡−𝑟𝑎𝑑𝑖𝑎𝑡𝑖𝑜𝑛 𝑛𝑜𝑛−𝑖𝑟𝑟𝑎𝑑𝑖𝑎𝑡𝑒𝑑 𝑘𝑖𝑑𝑛𝑒𝑦𝑠

𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑝𝑎𝑟𝑎𝑚𝑒𝑡𝑒𝑟 𝑖𝑛 𝑑𝑎𝑦−60 𝑝𝑜𝑠𝑡 𝑟𝑎𝑑𝑖𝑎𝑡𝑖𝑜𝑛 𝑖𝑟𝑟𝑎𝑑𝑖𝑎𝑡𝑒𝑑 𝑘𝑖𝑑𝑛𝑒𝑦𝑠

𝐷𝑎𝑦 60 𝑓𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒 = 𝑣𝑒𝑟𝑎𝑔𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑝𝑎𝑟𝑎𝑚𝑒𝑡𝑒𝑟 𝑖𝑛 𝑖𝑛 𝑑𝑎𝑦−60 𝑝𝑜𝑠𝑡−𝑟𝑎𝑑𝑖𝑎𝑡𝑖𝑜𝑛 𝑛𝑜𝑛−𝑖𝑟𝑟𝑎𝑑𝑖𝑎𝑡𝑒𝑑 𝑘𝑖𝑑𝑛𝑒𝑦𝑠

Equation 5

Equation 6

The value of fold change for 3D vessel structural parameters was calculated to investigate the time
response of irradiated kidneys. The fold change provides a quantitative index for the severity of
changes caused by radiation at day-60 and day-90. The smaller is the value of fold change, the
more severe are the damages that were caused by radiation. Table 2 presents the value of fold
change for total vessel volume, vessel density, maximum branch death, and the number of terminal
points at day-90 and day-60 post-radiation. The result in Table 2 illustrates that the value of fold
change for all parameters is notably smaller at da-90 compared to day-60. It means that the effect
of radiation on total vessel volume, vessel density, maximum vessel branch depth and the number
of vessel terminal points are more pronounced at day-90 post-radiation compared to day-60.
Table 2: The fold changes for day-90 and day-60 post radiation.

Harvesting
Day

Total Vessel
Volume

Vessel
Density

Fold

60

0.7376

Change

90

0.4490

Table 3

# Vessel
Terminal
Points

0.8861

Maximum
Vessel
Branch
Depth
0.9004

0.4337

0.72

0.4818

0.9178

contains the average value ± standard deviation of the measurement that were done on all

the 3D vessel structural parameters. As Table 3 shows, for 0 grey radiation, total vessel volume,
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vessel density, maximum vessel branch depth, and the number of terminal points has increased at
day-90 compared to day-60. These results were expected since by the time of harvesting the
kidneys, the rats had not reached their complete physical growth. For 12.5 grey radiation, Table 3
shows that for 12.5 Grey irradiated kidneys, the changes in the average of total vessel volume,
vessel density, maximum vessel branch depth and the number of terminal points by day 90 are
more intense compared to those of day 60. This observation manifests the time-response of
radiation on kidney vessels.
Table 3: The average of measured vessel parameters and their standard deviation.

Radiation
Dosage

Harvesting
Day

Total Vessel
Volume×
𝟏𝟎𝟗 𝝁𝒎𝟑

Vessel
Density

0 Grey

60

13.421±4.6184

12.5 Grey

3.9%±1.14%

Maximum
Vessel
Branch
Depth
16.5±2.43

# Vessel
Terminal
Points
160.17±34.55

90

18.269±2.9164 4.18%±0.79%

16.67±2.34

198.67±30.04

60

9.8997±2.5969 3.45%±1.11%

14.86±2.19

147±30.28

90

8.2020±3.2778 1.81%±0.63%

12±3.87

95.71±53.68

Two-factor repeated ANOVAs was applied on all the data for dose-response at day 60 and day 90.
For a better understanding of the dose-response, the data in Table 3 are exhibited in
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23.

Figure

Figure 23

displays the bar graph and the statistical results for total vessel volume, vessel density,

maximum branch depth and number of terminal points in all samples of our four groups.
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Figure 23a shows the changes in total vessel volumes. Since by using VMI method, we are only able

to detect the vessels that carry blood, the total vessel volume is also an indicator of total blood
volume.

Figure 23a reveals

by

26%

that 12.5 Grey radiation at day 60 post-radiation reduced the total blood volume
and

55%

at

day

86

90

after

radiation.

Figure 23b

illustrates that vessel density has drop by 11% and 57% after 60- and 90-days post-

radiation,

respectively.

Figure 23c displays

that the maximum branch depth for 12.5 Grey has decreased by 10% compared

to 0 gray at day 60, however, this decrease is 28% on day 90 post-radiation. The number of terminal
points is a good estimation for the number of vessels that could be detected in a sample. The bar
graphs

in
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Figure 23d shows the statistics for the number of vessels in all samples, and it reveals that receiving

12.5 grey radiation diminishes the number of terminal points on day 60 only by 8%. Despite this
little change on day 60, the number of terminal points is noticeably lower for 12.5 compared to
those of 0 Grey on day 90. The results of repeated ANOVAs on these parameters show that total
vessel volume, vessel density, maximum branch depth and the number of terminal points is
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significantly lower in the irradiated group at day-90 (with a criterion of P < 0.05). This confirms
that the changes caused by 12.5 grey radiation are more evident 90 days after radiation compared
to 60 days post-radiation.
The kidney is a richly perfused organ that renal blood flow (RBF) accounts for almost 25% of the
cardiac output [96]. Therefore, being able to measure the blood volume in vessel would provide
us with useful information about kidney perfusion. Using VMI method, vessel diameter would be
a god indicator of blood perfusion in kidney. Although our result shows that the vessel mean
diameter after radiation is decreased, the number of detected vessels had shrunk too (the decrease
in the number of endpoints). Consequently, the average vessel diameter in each sample did not

Figure 23: The average of measurements on all the kidneys in bar plots± standard deviation. (a) Total vessel
volume diameter± standard deviation for 12.5 Grey (irradiated group) and 0 Grey (non-irradiated group) 60 and
90 days after radiation. The total vessel volume r has dropped 26% 60 days after radiation and 55% 90 days after
radiation. (b) The average of vessel density ± standard deviation for irradiated group and control group 60 and 90
days after radiation. The total vessels volume decreased by 26% at day-60 post-radiation and 55% at day-90 postradiation. (c) The average of Maximum branch ± depth standard deviation for irradiated group and control group
60 and 90 days after radiation. The Maximum branch depth is reduced by 10% and 28% for 60 and 90 days after
radiations, respectively. (d) The average of the number of terminal points ± depth standard deviation for the
irradiated group and control group 60 and 90 days after radiation. The number of terminal points diminished by
8% and 52% for day-60 and 90 post-radiation, respectively. *, a significant difference of the vessel density, the
maximum branch depth and between the number of terminal points between the irradiated group and nonirradiated at day-90 post-radiation with the criteria of P<0.05.
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change significantly and the effect of radiation on vessel diameter was not conveyed by measuring
the average of vessel mean diameter. Hence, to illustrate the effect of radiation on the vessel mean
diameter, we counted the number of vessels in different diameter ranges. Table 4 shows the number
of vessels in different ranges, with a span of 100 µm. This data shows that the number of vessels
in all ranges on day-90 post-radiation has decreased. With a closer look at day-60 data, we realize
that the number of vessels in smaller ranges (70-150 µm, 250-450 µm), has increased and the
number of vessels in larger ranges (450-850 µm) has decreased in the irradiated group. This might
suggest that although by day-60 radiation narrows the larger vessel vasculogenesis or angiogenesis
would be continued. Two-factor repeated ANOVAs was applied on all the data in table 3 for doseresponse at day-60 and day-90. With the criteria of P<0.005, the number of vessels in irradiated
kidneys on day-90 was significantly lower in ranges of 150-250 µm, 250-350 µm, 350-450 µm
and 750-850 µm. No significant decrease at day-60 vessel diameter was observed. Table 4 also
confirms our observation that by day-90, radiation more severely damages the kidneys in
comparison with day-60.

Table 4: The number of vessels that was detected for different ranges of 100 µm span and stars (*) mark the values in
the FR-irradiated group that are significantly different from mom-irradiated group with the criteria of P<0.05.
Harvesting

Radiation

70-150

150-250

250-350

350-450

450-550

550-650

650-750

750-850

Day

dosage

µm

µm

µm

µm

µm

µm

µm

µm

60

0 Grey

131.1667

111.1667

49

22.1667

9

4.3333

1.5

0.5

12.5 Grey

136.7143

105.5714

67.1429

25.7143

7.5714

0.5714

0.1429

0.2875

0 Grey

151.1667

125.8333

85.8333

30.5

11.1667

3.6667

1.6667

2.1667

12.5 Grey

86.4286

25.8571*

25.8571*

12.1429*

6.8571

1

0

0*

90

90

Chapter 4
Conclusion and Future Direction
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4. Conclusion and future direction
The in vivo fluorescence imager uses redox ratio as a biomarker of the metabolic state of a tissue.
I designed and implemented the second version of the in vivo fluorescence with main changes
including removing the excitation filter wheel and replacing the Nikon light source with Xcite
LED1. This alteration reduced operation cost, phototoxicity, experiment time, weight, and size of
the instrument. I also developed user interfaces for both versions that reduced the experience time
by 80%. The result of our study on wounds of diabetic mice showed that in vivo fluorescence
imager successfully monitored the effect of 670 Far-red photobiomodulation on diabetic wounds.
It indicates that our non-invasive, non-contact and portable in vivo fluorescence imager can
distinguish the impaired diabetic wound and detect the efficiency of interventions for wound
healing by tracking the mitochondria dysfunction and ROS concentrations during wound healing.
Additionally, to make this instrument more convenient for clinical trials, I changed the assembly
by separating the optical part from the hardware part. As a result, the in vivo fluorescence imager
became more manageable for the user. Furthermore, it provided more degrees of freedom to move
the optical part, so different parts of a patient body became more accessible. Consequently, it
minimized the change of position that would have been needed from the patient.
The characteristics of the second version of the in vivo fluorescence imager made it suitable for
the clinical setting. A future human pilot study can confirm that it can be highly beneficial to be
used in wound care centers for monitoring the efficiency of interventions on diabetic wound
healing. Moreover, there are many other fluorophores in the skin that are marker of multiple
injuries and interventions. The in vivo fluorescence imager can easily track these markers when
choosing the appropriate excitation wavelength and emission filters. For example, by imaging
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other fluorophores like porphyrin and collagens, the human acnes [97] and microvascular diseases
in type1 diabetes [98] can be studied.
We use the 3D cryo-imaging system to study the metabolic state of tissue by tracking NADH and
FAD. Besides, by utilizing the 3D cryo-imaging system a vessel segmentation method was
developed in our lab to extract the 3D vessel network of the different organ. I validated the vessel
segmentation method by Murray’s law and used it to quantitatively investigate the dose-response
and time-response of ionizing radiation in the vessel structure of a rat's kidney. The results showed
that this method successfully segmented the perfused vessels in kidneys and manifest the vessel
structure anatomical damage caused by radiation.
This method is also applicable for extracting the 3D vessel network in other organs like lungs,
liver, heart and cancerous tumors. Therefore, it can be used to investigate various disease-induced
anatomical injuries to vessel structure. Moreover, by improving the 3D cryo imaging resolution to
microscopic level, the effect of disease on capillary vessels and consequence cellular changes can
be monitored too.
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